Major Advance in Hepatitis C Therapy
August 26, 2010
August 26, 2010
WILLIAMSBURG, Ky., Aug. 26 -- University of the Cumberlands issued the following news release:
In what's being called the start of a new era in treating hepatitis C, a team that includes a leading Miller School physician has discovered a drug that appears to dramatically increase the success of standard therapy.
For decades, patients with hepatitis C have faced an unpleasant reality: the standard therapy is effective in only 40 percent of cases and the side eff . . .
In what's being called the start of a new era in treating hepatitis C, a team that includes a leading Miller School physician has discovered a drug that appears to dramatically increase the success of standard therapy.
For decades, patients with hepatitis C have faced an unpleasant reality: the standard therapy is effective in only 40 percent of cases and the side eff . . .